TRPC5 and kidney disorder: Interestingly, Adora2b, which mediates renal AMP-activated protein kinase (AMPK) activation (29), and Trpc5, whose abnormal expression was suggested to interfere with progressive kidney diseases (30), were subsequently altered at the methylation level due to postnatal protein restriction.